XBiotech XBIT
NASDAQ XBIT
$2.18 +0.03 (+1.40%)
At close: Sep 29, 2026 · 4:00 PM EDT

XBiotech (XBIT) EBITDA Margin (2020 - 2022)

Updated

XBiotech's EBITDA Margin came in at -794.91% for FY2022, down 672.95 percentage points from -121.96% in FY2021.

Analysis

XBiotech (XBIT) EBITDA Margin (2020 - 2022) Analysis & Trends

  • Per Business Quant, earlier years put EBITDA Margin at -121.96% in FY2021 (-85.51 pp) and -36.45% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 35.95%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 49.01%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 6.02%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 33.11%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 46.01%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 39.10%
10 XBiotech 65.55 Mn 65.55 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -336.61%
Jun 30, 2022 -742.94%
Mar 31, 2022 -1,427.00%
Dec 31, 2021 -144.24%
Sep 30, 2021 -67.36%
Jun 30, 2021 -220.27%
Mar 31, 2021 -60.45%
Dec 31, 2020 -82.29%
Sep 30, 2020 -39.07%
Jun 30, 2020 -38.51%
Mar 31, 2020 -12.72%
API Access

XBiotech EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=XBIT&period=max&api_key=YOUR_API_KEY